Ethical standards of very high-quality ensures the authenticity of the scientific publication and wins the public trust on scientific findings so that it enhances the credibility of the research work or idea.
Hilaris considers only the original research work that has neither been published elsewhere, nor under process of reviewing for publication. Hilaris deploys authenticated software tool to detect similar and overlapping of information in the submitted documents. Information that is found to have been plagiarized from the manuscripts of other authors would be summarily rejected, involving thorough changes as suggested by the reviewers.
A publication that overlaps or relates substantially with any other article that is already published, in press, or under consideration/submission is considered as Duplicate or redundant publication. Duplicate or redundant submission is identical manuscript (or having the similar data) that is submitted to various journals for publication. International copyright laws, ethical conducts, and cost effective use of resource ensure originality of the manuscript submitted.
Manuscripts must be original and should not have published or submitted elsewhere while it s under consideration for publication with a publisher. According to the APA code of ethics (APA Publication Manual, 2010) duplicate publication is violation of publication ethics and will be rejected.
If the author has any doubts related to re-using of a figure published elsewhere or that has been copyrighted, then s/he should seek advice from the editorial board members that is handling their manuscript. In such cases, he author must provide documentation from the previous publisher or the copy right holder’s permission for the figure to be re-published. In case if the author was not aware of the violation of the code and the material has been published, then measures must be taken to correct the same by submitting the manuscript with necessary amendments to rectify the ethical violation.
Any Submitted document which is found to contain citations with a motto to increase the number of citations of a given author, it will be considered as citation manipulation.
If the submitted documents are identified as fabricated or falsified with the experimental results consisting manipulated images, it is considered as falsification or fabrication consents.
All listed or mentioned authors should have made a significant contribution towards the research work submitted and should be approving all its claims. It is necessary to list out the specific individual that made significant contribution, including the students or any laboratory technicians.
In order to maintain transparency and help readers to form their own judgements of potential bias, authors should declare any competing financial interests related to the work described or presented.
During submission, policy entails that every author should reveal financial interests or collaborations, which may be direct or indirect and may raise the question of conflict or bias in the submitted work or in the conclusions, opinions given or implications, or any other sources of funding for related direct or indirect academic competition.
However, in the case of accepted manuscript, Conflict of Interest information should be mentioned as a statement in the document.
Permission is essential to reproduce material from the copyright holder. Articles cannot be directly published without these permissions.
It is very essential to protect patient’s right to privacy. Kindly collect and preserve copies of patient’s consent forms that mention patients or other themes of your experiments clearly. Take enough care to protect their identities while submitting the document for publication as photographs or any other material that may recognise them. If the consent forms are not obtained, then, it is requested to obtain one or to remove the elements that may reveal the individual identities from the document. However, the obtained statement must be included in the ‘Methods’ section of your manuscript. If required the Editors may request a copy of the consent forms.
All the manuscripts dealing with the original human or animal data should include a statement on ethics approval at the commencement of the Methods section. Also, should contain the mentioned information: the name and the address of the responsible ethics committee, the protocol number, along with the date of approval that is attributed by the ethics committee mentioned.
The paragraph can declaim, for example:
"Ethical approval for this study was given by the Ethical Committee of specific University or Hospitals, of certain place, on specific date."
Furthermore, as detailed above for the studies carried on human participants, it is necessary to state evidently that you have obtained the written consent from the participants that s/he has read and understood the details and they are participating in it with their personal consent. Kindly, refer the latest version of the Declaration given by the specific organization. Similarly, experiments that involve animals, you must provide the state of animal care and licensing guidelines under which the study was performed and is reported. This should be provided in accordance with the ARRIVE statement (Animals in Research: Reporting In Vivo Experiments). In any case, if ethics clearance was not obligatory or if there was any deviation or change from the standard of ethical requests, it is required to state the specified reason. Though, please note that the editor/s might ask you to provide evidence of ethical approval. Besides, If you have approval from a National Drug Agency (or similar) please state this and provide details, this can be particularly useful when discussing the use of unlicensed drugs.